Quarterly Result30 May 2026, 08:32 pm
Vanta Bioscience: Audited Results for FY26 Approved
AI Summary
Vanta Bioscience Ltd's board approved audited standalone and consolidated financial results for the half year and financial year ended March 31, 2026. Mr. Dopesh Raja Mulakala has been re-appointed as Managing Director for another 3 years effective April 18, 2026, subject to shareholder approval. The statutory auditors, M/s Mathesh & Ramana, issued an unmodified opinion on the financial results. The meeting was held on May 30, 2026, from 6:00 PM to 7:00 PM.
Key Highlights
- Audited standalone and consolidated financial results for FY26 approved.
- Dopesh Raja Mulakala re-appointed as Managing Director for 3 years.
- Auditors issued an unmodified opinion on FY26 financial results.
- Meeting commenced at 6:00 PM and concluded at 7:00 PM on May 30, 2026.
Price Impact
More from VANTABIO